Document Detail


Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings.
MedLine Citation:
PMID:  15085888     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The nutritional significance of long-chain polyunsaturated fatty acids (LCPS) during the perinatal period is becoming increasingly important. There are currently very few studies on dietary intervention during gestation. The aim of the study was to analyze the effect of docosahexaenoic acid (DHA) supplementation during pregnancy on levels in both the newborn and the mother. A randomized placebo controlled study was carried out on 20 pregnant women in study group receiving 200 mg/day of docosahexaenoic acid-(DHA) during the last trimester of pregnancy. Results in both groups (A supplemented, B non-supplemented) highlighted a decrease in plasma arachidonic acid (5.99 +/- 0.91 vs. 4.51 +/- 0.71 p<0.001 for group A and 5.84 +/- 0.71 vs. 4.80 +/- 0.51 p<0.01 for group B) in the baseline-final intra-group comparison. The intergroup comparison revealed a significant difference in plasma DHA at delivery: it was found to be higher in the population of supplemented pregnant women (3.17 +/- 0.26 vs. 2.77 +/- 0.31). The neonate population displayed no significant differences between the two groups. The results show that LCPS are consumed during the final stages of pregnancy and that oral supplementation with 200 mg/day of DHA is reflected in an increase in the plasma level of this fatty acid in the mother. One could speculate that there would be a corresponding increase in DHA bioavailability for the fetus.
Authors:
Pablo Sanjurjo; Jose I Ruiz-Sanz; Pilar Jimeno; Luis Aldámiz-Echevarría; Lourdes Aquino; Roberto Matorras; Judit Esteban; Montserrat Banqué
Related Documents :
8760238 - Renal reserve during human pregnancy.
9398648 - The placenta is not the main source of leptin production in pregnant rat: gestational p...
7432728 - Phenytoin metabolism in pregnancy.
11157328 - Changes in the maternal essential fatty acid profile during early pregnancy and the rel...
10996698 - Assessment of fetal cerebellar volume using three-dimensional ultrasound.
22337738 - Is carbamazepine safe to take during pregnancy?
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of perinatal medicine     Volume:  32     ISSN:  0300-5577     ISO Abbreviation:  J Perinat Med     Publication Date:  2004  
Date Detail:
Created Date:  2004-04-16     Completed Date:  2004-06-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0361031     Medline TA:  J Perinat Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  132-6     Citation Subset:  IM    
Affiliation:
Unit of Infant Metabolism, Department of Pediatrics, Hospital de Cruces, Baracaldo, Spain. psanjurjo@hcru.osakidetza.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Dietary Fats
Dietary Supplements*
Docosahexaenoic Acids / administration & dosage*,  blood
Female
Humans
Infant, Newborn / blood
Pregnancy
Pregnancy Trimester, Third / blood*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Dietary Fats; 25167-62-8/Docosahexaenoic Acids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oxytocic activity of thrombin: modulation of thrombin-induced gravid rat myometrial contractions by ...
Next Document:  Atosiban treatment for uterine hyperactivity during active labor: a pilot study.